During ovarian follicle growth, precise regulation of the onset of androgen production by ovarian theca-interstitial cells (TIC) is necessary for maintaining follicle viability. Thus, temporary suppression of TIC androgen production in preantral follicles is the key to promoting follicle development. Evidence indicates that this process is coordinated via intraovarian growth factors. Hepatocyte growth factor (HGF) can induce granulosa cell (GC) proliferation and suppress follicular atresia, indicating a role for HGF in promoting follicle growth and viability. To determine whether HGF could reversibly suppress androgen production, this study investigated the effect of HGF on TIC differentiation and steroid production. Twenty-six-dayold rats were used in all studies. HGF messenger RNA (mRNA) expression in TIC and GC was determined by reverse transcription-PCR. Agarose gel electrophoresis of the PCR products yielded a single band corresponding to the 290-bp HGF product for both TIC and GC. HGF expression in cultured TIC and GC was not blocked by gonadotropins or HGF. To investigate the effects of HGF on TIC steroidogenesis, TIC were isolated from the ovaries of hypophysectomized rats. TIC (3.0 ϫ 10 4 cells/well) were cultured with LH (0 -3 ng/ml) and/or HGF (0 -100 ng/ml) for 48 h, and androsterone levels were measured by RIA. HGF did not alter androsterone levels in the absence of LH; however, HGF reversibly impaired LH-dependent androsterone production by as much as 57% (IC 50 ϭ 1.5 Ϯ 0.01 ng/ml). LH (0.3 ng/ml) stimulated progesterone (P 4 ) synthesis by TIC (1201 Ϯ 190 pg/ml) compared to that by control cells (210 Ϯ 30 pg/ml). HGF stimulated basal P 4 production, and LH-dependent P 4 synthesis was augmented 2.6-fold by HGF (ED 50 ϭ 0.3 Ϯ 0.01 ng/ml). The DNA content and cell viability in TIC cultures were not affected by HGF. The effect of HGF on steroidogenic enzyme gene expression in TIC was also investigated via PCR. HGF did not alter the level of basal or LH-induced P450 side-chain cleavage and 3␤-hydroxysteroid dehydrogenase mRNAs; however, LH-dependent P450 17␣ hydroxylase/ C 17,20 lyase mRNA content was reduced 4.5-fold in the presence of HGF. Thus, HGF is expressed in both TIC and GC obtained from the immature rat ovary, suggesting its presence in growing follicles. In TIC, HGF stimulated P 4 synthesis, but impaired androgen production, concurrent with a down-regulatory effect on P450 17␣ hydroxylase/C 17,20 lyase gene expression. Collectively, these results indicate that HGF reversibly impairs LH-stimulated androgen production in TIC. Such effects may help promote folliculogenesis. (Endocrinology 138: [691][692][693][694][695][696][697] 1997) 
D evelopment of the ovarian follicle is a dynamic process involving highly coordinated proliferation and differentiation of the theca-interstitial cells (TIC) and granulosa cells (GC). Although differentiation of GC is necessary for estrogen (E 2 ) production, E 2 production is also dependent upon the presence of TIC-derived androgen substrate. Thus, the differentiation of TIC from steroidogenically inactive cells into androgenic cells is a key step during follicular growth and maturation. TIC differentiation occurs during preantral follicle development and involves expression of the steroid pathway biosynthetic enzymes, cytochrome P450 side-chain cleavage (P450 scc ), 3␤-hydroxysteroid dehydrogenase (3␤HSD), and cytochrome P450 17␣ hydroxylase/ C 17, 20 lyase (P450 17␣ ). These enzymes catalyze the stepwise conversion of cholesterol to progestins and, ultimately, androstenedione. Importantly, androgen production by differentiated TIC must be carefully regulated because premature production of androgens could lead to apoptosis in GC (1, 2) and, hence, the demise of the follicle.
LH is the hormone principally responsible for stimulating TIC differentiation; however, studies have shown that intraovarian growth factors, cytokines, and steroids can promote or suppress the effects of LH on steroidogenic differentiation of TIC into androgen-producing cells (3, 4) . No single intraovarian factor to date has been identified to be solely responsible for this important regulatory process. Indeed, genetic knockout experiments with a variety of growth and differentiation factors indicate that redundancy exists in the regulation of critical functions such as reproduction. It is uncertain whether a cohort of factors is indeed necessary, or whether an unidentified single regulatory factor governs TIC differentiation into androgen-producing cells.
Hepatocyte growth factor (HGF) is an 87-kDa cytokine initially characterized as an angiogenic factor that promotes DNA synthesis in primary epithelial cell cultures (5) . Subsequent studies have shown that in addition to its mitogenic function, HGF induces cell motility (5) ; moreover, HGF messenger RNA (mRNA) is expressed in fetal and neonatal rat tissues (6) as well as human placenta (6) . Hence, it has been suggested that HGF may have a role in regulating cell pro-liferation and differentiation during tissue development and remodeling (6, 7) .
Recently, HGF mRNA has been detected in murine ovaries (8) and bovine TIC (9) ; in the adult mouse, the HGF receptor was found in growing follicles (10) . Furthermore, HGF protein was detected in the conditioned medium from bovine TIC cultures (9) . In bovine GC, HGF induced cell growth in vitro (9) , and although prior studies have not determined whether HGF is present in the rat ovary, in cultured rat antral follicles HGF delayed the onset of apoptosis (11) . Based on these studies, it is possible that in the recruited cohort of growing follicles, TIC-derived HGF acts locally to promote follicle maturation by 1) stimulating mitosis and 2) preventing apoptosis in GC. Because TIC androgen production is essential for ovulation, but aberrant androgen levels are detrimental to folliculogenesis (1, 2) , there must be mechanisms in the ovary to prevent premature increases in androgen production. As the effects of HGF are consistent with a follicle growth-promoting role, this study was performed to determine whether HGF might be an intraovarian factor capable of reversibly suppressing TIC androgen synthesis.
Materials and Methods

Reagents and supplies
Recombinant human HGF/scatter factor (HGF) was purchased from Becton Dickinson (Bedford, MD). Ovine LH (AFP-555 1B; 2.3 NIH-S1 U/mg) and recombinant human FSH (FSH-R1) and were donated by the National Hormone and Pituitary Program of the NIDDK, NICHHD, and USDA (Rockville, MD). Ninety-six-well culture plates were purchased from Falcon (Lincoln Park, NJ). McCoy's 5a medium and medium 199 were purchased from Life Technologies (Grand Island, NY).
Animals
Immature female Sprague-Dawley rats (Harlan Industries, Indianapolis, IN) were used in all studies. Rats from which TIC were isolated were hypophysectomized by Harlan at 21 days of age. Rats arrived on day 25 and were allowed water (containing 5% dextrose) and food ad libitum. On day 26, rats were rendered unconscious via CO 2 inhalation and killed by cervical dislocation as approved by the Cedars-Sinai animal care and use committee. Ovaries were removed and placed in ice-cold medium 199 containing 25 mm HEPES and supplemented with 0.1% BSA (Sigma Chemical Co., St. Louis, MO).
Cell culture
Theca-interstitial cells. Highly purified populations of TIC were obtained from the enzymatically dispersed ovaries of hypophysectomized (Hx) rats via Percoll density gradient centrifugation, as previously described (12) . TIC (3.0 -4.0 ϫ 10 4 viable cells/200 l final volume⅐well) were cultured in 96-well culture plates. Control TIC were incubated in McCoy's 5a medium (M5a, serum-free and supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin sulfate, and 2 mm l-glutamine) without hormones. Treatments consisted of LH (0.003-3.0 ng/ml), HGF (0.1-100 ng/ml), or a combination of LH and HGF. The range of HGF concentrations was chosen to bracket the reported K d (0.3 nm) for HGF binding in epithelial cells in vitro (5) . Cultures were terminated at 6 -96 h (as described below), and the culture-conditioned medium was collected and stored at Ϫ20 C until RIAs for progesterone (P 4 ) (13), androstenedione (14) , and androsterone (15) .
To evaluate whether the effects of HGF were reversible, TIC were incubated in the presence of LH (0.3 ng/ml) and HGF (50 ng/ml) for 48 h, at which time culture-conditioned media were removed and frozen. The TIC were washed in situ with fresh M5a, then challenged with LH (0.3 ng/ml) for an additional 48 h (total of 96 h in vitro). Androsterone levels in culture-conditioned medium were measured by RIA.
GC.
To obtain GC for HGF mRNA expression studies, ovaries were removed from 26-day-old intact rats, and GC were obtained by follicle puncture as previously described (16) . GC were washed via centrifugation (3 min at 250 ϫ g), and the GC pellet was resuspended in M5a. Isolated GC were counted using a hemacytometer, and cell viability was determined by the trypan blue exclusion method. GC (4.0 -5.0 ϫ 10 4 /200 l final volume⅐well) were cultured in 96-well plates for 48 h. Treatments consisted of FSH (0.1 IU/ml) or HGF (50 ng/ml). Control GC were incubated in M5a without hormones.
Determination of TIC viability and DNA content in the presence of HGF
To determine the effect of HGF on cell viability, TIC were incubated (as described above) in the presence and absence of LH (0.3 ng/ml), with and without HGF (50 ng/ml). At 48 h, culture media were aspirated, and cells were washed with PBS, pH 7.0. Trypan blue (10% trypan blue in M5a; 50 l) was added to each well, and approximately 100 cells were immediately counted (per field) in 4 fields/well under light microscopy (ϫ20 magnification). The ratio of viable (clear) cells to nonviable (blue) cells was determined.
To investigate the effects of HGF on DNA content in TIC cultures, cells were incubated in 96-well plates. TIC were challenged with LH (0.3 ng/ml), HGF (50 ng/ml), or both LH and HGF. At 48 h, the culture media were removed, the wells were washed with PBS, and the cells were scraped from the wells using a rubber policeman. Cells were pooled (5-6 ϫ 10 5 ) according to treatment regimen, and DNA content was measured using a minidiphenylamine DNA assay as previously described (17) . Viability and DNA content determinations were performed in two independent experiments.
Measurement of HGF and steroidogenic enzyme mRNAs
The presence of HGF mRNA was determined by reverse transcription (RT) of cytoplasmic RNA extracts followed by amplification of specific complementary DNA (cDNA) sequences by semiquantitative PCR, as previously described (18) . Briefly, TIC were incubated for 48 h (as described above), with LH (0.3 ng/ml), HGF (50 ng/ml), or both LH and HGF. GC were cultured in the presence of FSH (0.1 IU/ml) or HGF (50 ng/ml) with and without FSH. TIC and GC control groups received M5a in the absence of hormones. To extract RNA, the conditioned media were removed, and the cells were lysed and harvested by scraping in 50 l ice-cold RNA extraction buffer [140 mm NaCl, 1.5 mm MgCl 2 , 10 mm Tris-HCl (pH 8.0), 0.5% Nonidet P-40, 1 mm dithiothreitol, and 20 mm vanadyl ribonucleoside complexes]. Four replicate wells were pooled, and RT was performed as previously described (18) . For PCR, oligonucleotide primers were synthesized in our lab (using an Applied Biosystems model 391 DNA synthesizer, Foster City, CA) that were previously shown to amplify a 290-bp region of the bovine HGF cDNA sequence (9) . The primers are completely homologous to bovine (9), rat (19) , and human (20) HGF cDNA. To control for variations in individual PCR reactions, a mutant control HGF cDNA fragment was synthesized by site-directed mutagenesis. In the HGF cDNA (19), a T was substituted for a G at base 778 to introduce an EcoRI restriction site. The resultant mutant HGF can be amplified by HGF primers, but can be distinguished from the amplified wild-type HGF by restriction digestion with EcoRI. The control cDNA (1 pg) was included in each PCR, and all samples from each experiment were amplified at the same time.
After 30 cycles of PCR in the presence of [ 32 P]deoxy-CTP, the amplification products were digested by EcoRI to cleave the mutant control cDNA. After the restriction enzyme digestion, products were separated on a 2% agarose gel stained with ethidium bromide. The radiolabeled bands were excised from the gel and counted in a ␤-spectrometer.
To verify that the PCR product was HGF mRNA, the 290-bp bands were cut from the gel, and DNA was extracted from the gel fragments using a Quiagen DNA extraction kit (Chatsworth, CA). The amplified region of the HGF gene contains a single StyI restriction digest site at base 811. Hence, aliquots of extracted PCR product were enzymatically digested with StyI for 3 h at 37 C and subjected to gel electrophoresis as described above. In addition, aliquots of the extracted DNA were sequenced using a silver sequencing kit obtained from Promega (Madison, WI).
To determine the effect of HGF on TIC steroid enzyme gene expression, TIC were cultured without hormones (control) or with HGF (50 ng/ml) or LH (0.3 ng/ml) in the presence and absence of HGF for 48 h. At 48 h, cultures were terminated, and RNA was extracted as described above. P450 scc , 3␤HSD, and P450 17␣ mRNA levels were measured using semiquantitative RT-PCR as described previously by our lab (18, 21, 22) .
Statistical analysis
Treatments were administered in triplicate, and each experiment was repeated a minimum of three times. Mean values from independent experiments were statistically analyzed by unpaired t test, and multiple comparisons were analyzed using one-way ANOVA followed by Tukey's test. Values were determined to be significant when P Յ 0.05.
Results
Expression of HGF in the rat ovary
If HGF is an intraovarian regulator of TIC androgen production it must be expressed in the ovary. To determine the cellular sites of HGF mRNA expression in the rat ovary, RT-PCR was performed on cytoplasmic extracts of pure populations of TIC and GC, with and without gonadotropin and/or HGF treatment. Electrophoresis of the TIC and GC PCR amplification products revealed a single band corresponding to the expected 290-bp HGF product (Fig. 1, gel,  upper band) . Furthermore, HGF was expressed in both the presence and absence of gonadotropins or HGF (Fig. 1, gel , lanes 2-5, 7, and 8, and lower panel). Partial DNA sequence analysis matched the obtained 290-bp PCR product with a region of the reported sequence of rat HGF. Furthermore, restriction digestion of the 290-bp PCR product with StyI yielded the appropriate fragments of 109 and 191 bp (not shown). This is the first report showing expression of HGF mRNA in the rat ovary and led us to determine role a for HGF in regulating TIC steroidogenesis.
Effects of HGF on TIC steroidogenesis
Having shown that HGF mRNA was expressed in the rat ovary, we next investigated the possible role of HGF in regulating TIC steroidogenesis. Although androstenedione is the predominant bioactive androgen synthesized in the mature rat ovary, in the immature rat ovary, androstenedione is rapidly and preferentially metabolized to androsterone (23) . Therefore, androsterone was used as the end point to measure androgen production in our experiments. To determine whether the observed effects of HGF were general effects on androgen production, androstenedione levels were also measured.
In TIC cultures, LH stimulated a dose-dependent increase in androsterone synthesis compared to controls (Fig. 2a) . At the maximal stimulatory concentration of LH (0.3 ng/ml), androstenedione production was also stimulated over that of controls (Fig. 2a, inset) . HGF (50 ng/ml) did not alter basal androsterone (Fig. 2a) or androstenedione (Fig. 2a, inset) levels. At the lower concentrations of LH (0.003-0.03 ng/ml), HGF did not affect LH stimulation of androsterone production. However, at 0.1 ng LH/ml and greater, HGF inhibited androsterone production. At the maximal stimulatory concentration of LH (0.3 ng/ml), HGF suppressed LH-dependent TIC androsterone production by more than 50% (Fig.  2a) . Moreover, the suppressive effects of HGF on LH-dependent androsterone production were concentration dependent (IC 50 ϭ 1.5 Ϯ 0.01 ng HGF/ml; Fig. 2b ). To determine whether HGF selectively impaired the synthesis of androsterone (by interfering with 4-ene-5␣-reductase and/or 3␣HSD), or inhibited androgen production at the level of P450 17␣ , androstenedione levels were also measured. Results showed that LH-stimulated androstenedione production was impaired by HGF (Fig. 2a, inset) , and this indicated 4 cells/well) were incubated in the presence and absence (control) of LH (0.3 ng/ml) or FSH (0.1 IU/ml), respectively. Separate TIC and GC cultures were challenged with HGF (50 ng/ml). At 48 h, cells were harvested, and RNA was extracted as described in Materials and Methods. The presence of HGF mRNA was determined by RT-PCR using oligonucleotide primers designed to amplify a 290-bp region of the rat cDNA sequence (8) . After digestion with EcoRI to cleave the mutant control cDNA, amplification products were separated on a 2% agarose gel stained with ethidium bromide (gel). Bands were cut from the gel and counted to determine relative mRNA levels (lower panel generalized inhibition of LH-stimulated androgen production.
A detailed time-course study showed that at 12-24 h, HGF did not impair LH-dependent androsterone production (Fig.  2c) , whereas beginning at 36 h (Fig. 2c) and beyond LHstimulated androsterone levels were suppressed by HGF. Therefore, it appears that HGF did not completely block TIC differentiation to the androgenic phenotype, and this is supported by the fact that in the presence of HGF, LH-dependent androstenedione and androsterone production remained significantly above control levels.
TIC viability was not affected by HGF, demonstrating that HGF was not cytotoxic to TIC (Table 1) . Also, HGF did not alter DNA content in TIC cultures, indicating that cell number was not altered by HGF.
As HGF suppressed LH-dependent androgen production by TIC, we examined the effect of HGF on P 4 synthesis to determine whether there was a generalized suppression of steroidogenesis by HGF. LH (0.1-3.0 ng/ml) stimulated P 4 synthesis by TIC compared to that by untreated control cells (Fig. 3a) . In the presence of LH (0.1 and 0.3 ng/ml), HGF significantly augmented P 4 levels (Fig. 3a) . Whereas in the absence of LH, HGF (0.1-50 ng/ml) induced a moderate, but significant (P Յ 0.05), increase in P 4 levels (Fig. 3b) . Additional studies showed that LH-stimulated P 4 production was augmented by HGF in a dose-dependent manner (EC 50 ϭ 0.3 Ϯ 0.01 ng/ml; Fig. 3b ). When TIC were challenged with 10 ng HGF/ml, LH-dependent P 4 levels were increased 2.6-fold (Fig. 3b) . Interestingly, at 100 ng HGF/ml, LH-dependent P 4 production was significantly reduced below that detected in cultures given LH without HGF. This effect could result from a down-regulation or desensitization of LH-induced signal transduction, such as observed in the sustained presence of high levels of LH and/or cAMP (4).
Reversibility of HGF suppression of TIC androgen production
In preovulatory follicles, copious amounts of androgens are required as the substrate for E 2 synthesis by GC. Therefore, if HGF were to play a physiological role in suppressing TIC androgen production in small follicles, HGF action must be reversible upon the removal and/or neutralization of HGF. Thus, experiments were conducted to evaluate the ability of TIC to recover from HGF-induced suppression of LH-dependent androgen production. First, TIC were concomitantly challenged with LH and HGF for 48 h. The cells were washed and then treated with LH alone for an additional 48 h (total of 96 h in vitro). The results indicated that HGF suppressed LH-dependent androgen production by TIC at 48 h (Fig. 4) . However, after an additional 48 h in the presence of LH without HGF (Fig. 4, 96 h ), TIC androgen production recovered and attained levels comparable to those present in TIC challenged with LH (in the absence of HGF) for the entire 96-h culture duration. This is an important finding and demonstrates that the androgen-suppressive effects of HGF in TIC are reversible. Control groups received M5a without hormones. B, Dose-dependent effects of HGF on LH-dependent androsterone production by TIC. TIC were treated with LH (0.3 ng/ml), HGF (0.1-100 ng/ml), or LH in the presence of HGF. Cultures in A and B were terminated at 48 h. C, Detailed time course for HGF effects on TIC androgen production. TIC were given LH (0.3 ng/ml), HGF (50 ng/ml), or LH and HGF for 6 -48 h. Conditioned media were assayed for androsterone (A, B, and C) and androstenedione (inset) concentration by RIA. Data are the mean Ϯ SEM of three independent experiments, with three replicates per experiment. Bars with different letters are significantly different (P Յ 0.05). TIC were isolated from the enzymatically dispersed ovaries of immature HX rats via Percoll density gradient centrifugation. TIC were challenged with LH (0.3 ng/ml), HGF (50 ng/ml), or a combination of LH and HGF. Control TIC were cultured in M5a without hormones. After a 48-h incubation, TIC viability was determined using the trypan blue exclusion method, as described in Materials and Methods. Values indicate the percentage of viable cells counted in four fields under light microscopy. In separate experiments, the DNA content of TIC cultures was measured after 48 h in vitro, using a minidiphenylamine DNA assay. Values represent the mean Ϯ SEM of two experiments.
Effect of HGF on TIC steroidogenic enzyme gene expression
HGF impaired LH-dependent androgen production in TIC cultures, concomitant with an increase in basal as well as LH-stimulated P 4 levels. Thus, we investigated the possibility that HGF-induced alterations in TIC steroid production resulted from effects at the level of P450 scc , 3␤HSD, and/or P450 17␣ mRNA expression. Results showed that HGF did not affect basal or LH-dependent levels of P450 scc and 3␤HSD mRNAs (Fig. 5, a and b) . Although basal P450 17␣ mRNA levels were not altered by HGF, LH-dependent P450 17␣ mRNA content was reduced by approximately 4.5-fold in the presence of HGF (Fig. 5c) . Although the HGF stimulation of P 4 levels cannot be explained by increased P450 scc and/or 3␤HSD mRNA expression in TIC, these results indicate that HGF-induced suppression of TIC androgen production is most likely mediated at least in part by a selective reduction in the expression of P450 17␣ , the rate-limiting enzyme in the conversion of P 4 to androgens.
Discussion
Based on the collective actions of HGF on TIC differentiation and steroidogenesis shown in this study, it could be hypothesized that HGF is an important component of the intrafollicular environment that promotes the viability of growing follicles. It is apparent that ovarian follicular development may be orchestrated by several locally produced factors, but the exact composition of the regulatory milieu is unknown. Furthermore, gene knock-out studies have demonstrated that fertility is not compromised in the absence of single growth factors (i.e. transforming growth factor-␣ (TGF␣) or keratinocyte growth factor) that have been shown to exert potent regulatory effects on ovarian cell growth and/or steroidogenesis (9, 24) . This strongly suggests that the overlap of growth factor-mediated steroid regulatory effects in TIC ensures the proper and timely onset of both androgen and P 4 production. Because of the distinct effects of HGF in TIC cultures, it is likely that HGF may work in concert with other previously characterized growth factors and cytokines (25) to suppress the synthesis of P450 17␣ and consequently retard androgen production by TIC surrounding preantral follicles. If this is the case, premature androgen production would be blocked, with subsequent benefit to the preantral follicles. FIG. 3 . The effect of HGF on P 4 production by TIC. TIC were obtained and cultured as described in Materials and Methods. TIC were incubated for 48 h in M5a alone (control) or with combinations of LH and HGF as described below. P 4 levels in culture-conditioned media were measured using RIA. Data are the mean Ϯ SEM of three independent experiments, with three replicates per experiment. A, TIC were cultured (200 l total volume/well) with LH (0.003-3.0 ng/ml) in the presence and absence of HGF (50 ng/ml). Significance (P Յ 0.03) between LH and LH plus HGF is denoted by a. B, Dose-dependent effects of HGF on basal and LH-dependent P 4 production by TIC. TIC were cultured with HGF (0.1-100 ng/ml) in the presence and absence of LH (0.3 ng/ml). Bars with different letters are significantly different (P Յ 0.05).
FIG. 4.
Reversibility of HGF-induced suppression of TIC androgen production. TIC were obtained and cultured as described in Materials and Methods. Designated cultures were incubated with LH (0.3 ng/ ml), HGF (50 ng/ml), or LH and HGF for 96 h. Control TIC received M5a without hormones. Media and treatments were changed and replenished at 48 h. Separate TIC cultures were concomitantly challenged with LH and HGF for 48 h, at which time medium was removed and replaced with fresh medium containing LH without HGF, and cells were incubated for an additional 48 h (96 h total). Androsterone levels in conditioned medium were measured using RIA. Data are the mean Ϯ SEM of three independent experiments, with three replicates per experiment. Bars with different letters are significantly different (P Յ 0.05).
This study extends prior findings which have indicated that HGF is involved in promoting follicle maturation due to its mitogenic (9) and antiatretogenic effects (11) . For example, it has been shown that HGF prevented the onset of atresia in antral follicles obtained from 27-day-old rats (11); importantly, elevated follicular androgen levels can induce apoptosis and follicular atresia (1, 2) . The manner by which HGF slowed atresia in the aforementioned report was not determined; however, the present studies showed that HGF impaired LH-stimulated androstenedione and androsterone synthesis in TIC, concurrent with a reduction in P450 17␣ mRNA levels. HGF suppression of TIC androgen production could be one mechanism by which HGF prevents the onset of apoptosis.
In contrast to its inhibitory effect on TIC androgen synthesis, HGF stimulated basal and LH-supported P 4 production by TIC, and this effect could not be attributed to HGFinduced alterations in the expression of P450 scc and 3␤HSD mRNAs. One likely mechanism is that decreased metabolism of P 4 to androgens in the presence of HGF caused an increase in the accumulation of P 4 in the culture medium. A selective inhibitory effect on TIC androgen production is not without precedent in the ovary, and indicates an important regulatory mechanism. For example, TGF␣ suppresses P450 17␣ mRNA expression and androgen production, but increases 3␤HSD mRNA levels in TIC (26) . TGF␤ selectively impairs androgen levels by specifically reducing P450 17␣ activity (27) .
Furthermore, TGF␤ augments LH-stimulated P450 scc content, concomitant with potentiating LH-dependent P 4 production in TIC (28) . Finally, in the presence of tumor necrosis factor-␣, LH-stimulated androstenedione production as well as P450 17␣ protein and activity are reduced, but P 4 production is not affected (29) . Thus, P450 17␣ is a common site of regulation, but none of the growth factors, including HGF, affects TIC in quite the same manner. This indicates that the control of TIC differentiation and androgen production is highly regulated and apparently fine-tuned by ovarian peptides that potentially operate through several intracellular mechanisms. The degree of growth factor-mediated redundancy is consistent with the concept that regulation of P450 17␣ is critically important for reproductive success.
The HGF receptor is present in developing and mature follicles in the adult mouse (10); thus, it is likely that follicles at early stages of development can respond to HGF. However, temporal regulation of HGF expression by intact growing follicles has not been investigated. The present study showed that neither HGF nor gonadotropins blocked HGF mRNA expression in isolated TIC and GC in vitro. Although these data suggest that LH, FSH, and HGF may not alter HGF mRNA levels, this is not conclusive evidence that HGF gene expression is unaltered by in vivo hormone dynamics. It is important to consider that nothing is presently known about the control of ovarian HGF synthesis in vivo. In other systems, it has been demonstrated that E 2 , TGF␤1, and glucocorticoids can affect HGF mRNA expression (8, 30) . Although the significance of these observations for ovarian follicle development is unknown, the observation that E 2 can block HGF mRNA expression raises the intriguing possibility that E 2 could be a physiological signal to suppress intrafollicular HGF production. HGF could be involved in suppressing TIC androgen production until the GC begin to produce E 2 . The E 2 would then block HGF production and release the TIC from HGF-directed inhibition. Androgen synthesis would increase, and the follicle could then secrete the large amounts of E 2 necessary to trigger ovulation. Further studies will be required to determine the temporal pattern of HGF production in developing follicles and the physiological role of HGF.
